269 related articles for article (PubMed ID: 29198562)
21. [Epidemiology of Alcoholic Liver Disease in Korea].
Lee SW
Korean J Gastroenterol; 2020 Aug; 76(2):55-59. PubMed ID: 32839366
[TBL] [Abstract][Full Text] [Related]
22. Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis.
Williams R; Aspinall R; Bellis M; Camps-Walsh G; Cramp M; Dhawan A; Ferguson J; Forton D; Foster G; Gilmore I; Hickman M; Hudson M; Kelly D; Langford A; Lombard M; Longworth L; Martin N; Moriarty K; Newsome P; O'Grady J; Pryke R; Rutter H; Ryder S; Sheron N; Smith T
Lancet; 2014 Nov; 384(9958):1953-97. PubMed ID: 25433429
[No Abstract] [Full Text] [Related]
23. Alcohol consumption and non-communicable diseases: epidemiology and policy implications.
Parry CD; Patra J; Rehm J
Addiction; 2011 Oct; 106(10):1718-24. PubMed ID: 21819471
[TBL] [Abstract][Full Text] [Related]
24. Trends in the management and burden of alcoholic liver disease.
Mathurin P; Bataller R
J Hepatol; 2015 Apr; 62(1 Suppl):S38-46. PubMed ID: 25920088
[TBL] [Abstract][Full Text] [Related]
25. Tackling the epidemic: the NCEPOD report on alcohol-related liver disease and the Lancet Commission on Liver Disease.
Kiat C; O'Mahony S
J R Coll Physicians Edinb; 2018 Dec; 48(4):291-292. PubMed ID: 30488880
[No Abstract] [Full Text] [Related]
26. The cost-effectiveness of testing for hepatitis C in former injecting drug users.
Castelnuovo E; Thompson-Coon J; Pitt M; Cramp M; Siebert U; Price A; Stein K
Health Technol Assess; 2006 Sep; 10(32):iii-iv, ix-xii, 1-93. PubMed ID: 16948891
[TBL] [Abstract][Full Text] [Related]
27. The economic cost of preventable disease in Australia: a systematic review of estimates and methods.
Crosland P; Ananthapavan J; Davison J; Lambert M; Carter R
Aust N Z J Public Health; 2019 Oct; 43(5):484-495. PubMed ID: 31390112
[TBL] [Abstract][Full Text] [Related]
28. Economic costs of excessive alcohol consumption in the U.S., 2006.
Bouchery EE; Harwood HJ; Sacks JJ; Simon CJ; Brewer RD
Am J Prev Med; 2011 Nov; 41(5):516-24. PubMed ID: 22011424
[TBL] [Abstract][Full Text] [Related]
29. The undertreatment of alcohol-related liver diseases among people with alcohol use disorder.
Scafato E; Caputo F; Patussi V; Balbinot P; Addolorato G; Testino G
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):974-982. PubMed ID: 32017006
[TBL] [Abstract][Full Text] [Related]
30. Health and economic burden of the projected obesity trends in the USA and the UK.
Wang YC; McPherson K; Marsh T; Gortmaker SL; Brown M
Lancet; 2011 Aug; 378(9793):815-25. PubMed ID: 21872750
[TBL] [Abstract][Full Text] [Related]
31. Economic costs of diabetes in the U.S. In 2007.
American Diabetes Association
Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
[TBL] [Abstract][Full Text] [Related]
32. Health economics of weight management: evidence and cost.
Kouris-Blazos A; Wahlqvist ML
Asia Pac J Clin Nutr; 2007; 16 Suppl 1():329-38. PubMed ID: 17392129
[TBL] [Abstract][Full Text] [Related]
33. Alcoholic liver disease - the extent of the problem and what you can do about it.
Hazeldine S; Hydes T; Sheron N
Clin Med (Lond); 2015 Apr; 15(2):179-85. PubMed ID: 25824072
[TBL] [Abstract][Full Text] [Related]
34. Projected prevalence and mortality associated with alcohol-related liver disease in the USA, 2019-40: a modelling study.
Julien J; Ayer T; Bethea ED; Tapper EB; Chhatwal J
Lancet Public Health; 2020 Jun; 5(6):e316-e323. PubMed ID: 32504584
[TBL] [Abstract][Full Text] [Related]
35. The health and economic burden of smoking in 12 Latin American countries and the potential effect of increasing tobacco taxes: an economic modelling study.
Pichon-Riviere A; Alcaraz A; Palacios A; Rodríguez B; Reynales-Shigematsu LM; Pinto M; Castillo-Riquelme M; Peña Torres E; Osorio DI; Huayanay L; Loza Munarriz C; de Miera-Juárez BS; Gallegos-Rivero V; De La Puente C; Del Pilar Navia-Bueno M; Caporale J; Roberti J; Virgilio SA; Augustovski F; Bardach A
Lancet Glob Health; 2020 Oct; 8(10):e1282-e1294. PubMed ID: 32971051
[TBL] [Abstract][Full Text] [Related]
36. Missed opportunities for intervention in alcohol-related liver disease in the UK.
Burton R; Sheron N
Lancet Gastroenterol Hepatol; 2017 Jul; 2(7):469-471. PubMed ID: 28606872
[No Abstract] [Full Text] [Related]
37. Alcohol-related liver disease: Clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH).
Arab JP; Roblero JP; Altamirano J; Bessone F; Chaves Araujo R; Higuera-De la Tijera F; Restrepo JC; Torre A; Urzua A; Simonetto DA; Abraldes JG; Méndez-Sánchez N; Contreras F; Lucey MR; Shah VH; Cortez-Pinto H; Bataller R
Ann Hepatol; 2019; 18(3):518-535. PubMed ID: 31053546
[TBL] [Abstract][Full Text] [Related]
38. Growing burden of alcoholic liver disease in China: A review.
Wang WJ; Xiao P; Xu HQ; Niu JQ; Gao YH
World J Gastroenterol; 2019 Mar; 25(12):1445-1456. PubMed ID: 30948908
[TBL] [Abstract][Full Text] [Related]
39. The alcohol harm paradox: using a national survey to explore how alcohol may disproportionately impact health in deprived individuals.
Bellis MA; Hughes K; Nicholls J; Sheron N; Gilmore I; Jones L
BMC Public Health; 2016 Feb; 16():111. PubMed ID: 26888538
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
